What is the PreeclampsiaScreen™ | T1 test?

Suggested ad (PerkinElmer)

Our partners at PerkinElmer Labs/NTD have developed a new way to test for early onset preeclampsia. Read more so that you can begin an important conversation with your doctor about your risks.

The PreeclampsiaScreen™ | T1, developed by PerkinElmer Labs/NTD, an innovator in the field of prenatal screening for over thirty years, is an innovative test service that lets your doctor assess your risk of developing early onset preeclampsia as early as 10 weeks. That’s incredible! This test is the first early onset preeclampsia screening test in the United States and has been available only since 2013.

First trimester screening is a critical component of preeclampsia prevention as it lets your doctor begin to address any health concerns as soon as possible, before they mature into a truly serious condition. If found early, options such as increased monitoring, modified activity, bed rest and some medications can be recommended and help reduce or avoid the complications of early onset preeclampsia.

Ask your healthcare provider for more information about early onset preeclampsia and the PreeclampsiaScreen™ | T1 test.

Learn more

This ad is brought to you by PerkinElmer

Disclaimer: PreeclampsiaScreen™ | T1 test is a part of a lab service offering provided by PerkinElmer Labs/NTD. This test was developed and its performance characteristics determined by PerkinElmer Labs/NTD. It has not been cleared or approved by the U.S. Food and Drug Administration. The methods and performance characteristics have been reviewed and approved by the New York State Department of Health.
Find the Ovia app for you!
Get our app at the Apple App Store Get our app at the Apple App Store Get our app at the Google Play Store Get our app at the Google Play Store